Compound ID | 391
Sulopenem
Synonym(s): CP-70,429 | CP-70429 | CP70429 | CP 70429
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against multidrug resistant Gram-negatives infections in both the hospital and community settings |
| Description: | Penem-type; S-isomer of CP-65,207 |
| Institute where first reported: | Iterum Therapeutics Ltd. |
| Year first mentioned: | 1980 |
| Highest development stage: | Phase 3 (NCT03354598) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9950244 |
| Guide to Pharmacology: | sulopenem |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.